Abstract

BackgroundLentiviral vectors are efficient vehicles for stable gene transfer in dividing and non-dividing cells. Several improvements in vector design to increase biosafety and transgene expression, have led to the approval of these vectors for use in clinical studies. Methods are required to analyze the quality of lentiviral vector production, the efficiency of gene transfer and the extent of therapeutic gene expression.ResultsWe compared lentiviral vector titration methods that measure pg p24/ml, RNA equivalents/ml, transducing units (TU/ml) or mRNA equivalents. The amount of genomic RNA in vector particles proves to be reliable to assess the production quality of vectors encoding non-fluorescent proteins. However, the RNA and p24 titers of concentrated vectors are rather poor in predicting transduction efficiency, due to the high variability of vector production based on transient transfection. Moreover, we demonstrate that transgenic mRNA levels correlate well with TU and can be used for functional titration of non-fluorescent transgenes.ConclusionThe different titration methods have specific advantages and disadvantages. Depending on the experimental set-up one titration method should be preferred over the others.

Highlights

  • Lentiviral vectors are efficient vehicles for stable gene transfer in dividing and nondividing cells

  • Primers and probe are directed against the U5 region of the 5' LTR and the 5' end of the gag gene, sequences that are present in all HXB2-derived lentiviral vector constructs [18] (Figure 1A)

  • For basic studies and eventually clinical trials, it is imperative that the performance characteristics and the variability inherent with these titration methods are known

Read more

Summary

Introduction

Lentiviral vectors are efficient vehicles for stable gene transfer in dividing and nondividing cells. Methods are required to analyze the quality of lentiviral vector production, the efficiency of gene transfer and the extent of therapeutic gene expression. Since lentiviral vectors (LV) integrate stably into the host-cell genome of non-dividing cells such as neurons and in haematopoietic stem cells [1,2,3], they offer great potential for gene therapeutic applications [4]. Production of lentiviral vectors is routinely achieved by transient transfection of human embryonic kidney (293T) cells using high concentrations of the different plasmids, implicating the presence of residual plasmid DNA in the vector preparation, even after concentration. Transduction by lentiviral vectors (page number not for citation purposes)

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.